^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BXQ-350

i
Other names: BXQ-350, BXQ 350, SapC-DOPS, SapC, SapC-DOPS nanovesicles, Saposin C–dioleoylphosphatidylserine complexes
Associations
Trials
Company:
Bexion, Cincinnati Children's Hospital Medical Center
Drug class:
Apoptosis stimulant, S1P activator
Associations
Trials